Bath & Body Works Q4 2024 beats guidance; provides FY2025 outlook

Bath & Body Works, Inc.

2024-FY EPS reported $3.61 revenue$7,307,000,000

Q4 net sales $2,788M (down 4.3% YoY on 13 vs 14 weeks); GAAP EPS $2.09 vs $2.55.
Full-year 2024 adjusted EPS $3.29 vs $3.27; GAAP EPS $3.61 vs $3.84.
FY2025 guidance: net sales +1-3%, EPS $3.25-$3.60; Q1 EPS $0.36-$0.43.
Board authorizes new $500M share repurchase program, replacing ~$120M remaining.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.